Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.


Strengths

● Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.

● With a P/E ratio at 11.65 for the current year and 9.22 for next year, earnings multiples are highly attractive compared with competitors.

● The company shows low valuation levels, with an enterprise value at 0.5 times its sales.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Analyst opinion has improved significantly over the past four months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Over the past twelve months, analysts' opinions have been revised negatively.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.